Combination of two different dopamine agonists in the management of Parkinson's disease F. StocchiA. BerardelliS. Ruggieri Pages: s115 - s116
Evaluation of risk of Parkinson's disease in a cohort of licensed pesticide users N. VanacoreA. NappoG. Meco Pages: s119 - s120
Striatal dopaminergic denervation in early and late onset Parkinson's disease assessed by PET and the tracer [11C]FECIT: preliminary findings in one patient with autosomal recessive parkinsonism (Park2) A. AntoniniR.M. MorescoF. Fazio Pages: s51 - s52
Frequency, distribution and characteristics of progressive supranuclear palsy in Italy: preliminary observations A. BrusaS. Cammarata Pages: s63 - s64
Autosomal recessive early onset parkinsonism is linked to three loci: PARK2, PARK6, and PARK7 V. BonifatiM.C.J. Dekkerand the Italian Parkinson Genetics Network Pages: s59 - s60
Bipolar affective disorder and Parkinson's disease: a rare, insidious and often unrecognized association A. CannasA. SpissuP. Tacconi Pages: s67 - s68
Visualisation of the subthalamic nucleus: a multiple sequential image fusion (MuSIF) technique for direct stereotaxic localisation and postoperative control M. EgidiP. RampiniR.M. Villani Pages: s71 - s72
Noradrenergic loss enhances MDMA toxicity and induces ubiquitin-positive striatal whorls M. FerrucciM. GesiF. Fornai Pages: s75 - s76
Amantadine in Huntington's disease: open-label video-blinded study C. LucettiG. GambacciniU. Bonuccelli Pages: s83 - s84
Screening cognitive decline in dementia: preliminary data on the Italian version of the IQCODE V. IsellaM.L. VillaI. Appollonio Pages: s79 - s80
Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-up M. OnofrjA. ThomasA. Di Iorio Pages: s91 - s94
Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients L. PetrozziC. LucettiU. Bonuccelli Pages: s97 - s98
Cognitive and psychiatric characterization of patients with Huntington's disease and their at-risk relatives P. SoliveriD. MonzaF. Girotti Pages: s105 - s106
Movement-related modulation of neural activity in human basal ganglia and its L-DOPA dependency: recordings from deep brain stimulation electrodes in patients with Parkinson's disease A. PrioriG. FoffaniG. Scarlato†Pages: s101 - s102
Anatomo-clinical correlation of intraoperative stimulation-induced side-effects during HF-DBS of the subthalamic nucleus F. TammaE. CaputoA. Priori Pages: s109 - s110
The role of somatosensory feedback in dystonia: a psycophysical evaluation M. TinazziT. RossoS.M. Aglioti Pages: s113 - s114
PARK6 is a common cause of familial parkinsonism E.M. ValenteF. Brancatiand the European Consortium on Genetic Susceptibility in Parkinson's Disease Pages: s117 - s118
ALS-plus: 5 cases of concomitant amyotrophic lateral sclerosis and parkinsonism S. ZoccolellaG. PalaganoG. Iliceto Pages: s123 - s124
Common daily activities in the virtual environment: a preliminary study in parkinsonian patients G. AlbaniR. PignattiA. Mauro Pages: s49 - s50
Clinical assessment of dysphagia in early phases of Parkinson's disease M.A. VolontéM. PortaG. Comi Pages: s121 - s122
Body weight, levodopa pharmacokinetics and dyskinesia in Parkinson's disease G. ArabiaM. ZappiaA. Quattrone Pages: s53 - s54
Perfusion-weighted dynamic susceptibility (DSC) MRI: basal ganglia hemodynamic changes after apomorphine in Parkinson's disease L. BrusaA. BassiP. Stanzione Pages: s61 - s62
Effects of the intrastriatal administration of selective dopaminergic agonists on Fos expression in the rat brain F. BlandiniR. FancelluG. Nappi Pages: s57 - s58
Frontal intermittent rhythmic delta activity (FIRDA) in patients with dementia with Lewy bodies: a diagnostic tool? S. CalzettiE. BortoneD. Mancia Pages: s65 - s66
Modification of respiratory function parameters in patients with severe Parkinson's disease M.F. De PandisA. StaraceF. Stocchi Pages: s69 - s70
Psychophysiological approach in Parkinson's disease: L-dopa effects on preprogramming and control activity F. FattappostaF. PierelliG. Amabile Pages: s73 - s74
Frequency of apraxia of eyelid opening in the general population and in patients with extrapyramidal disorders P. LambertiM. De MariG. Defazio Pages: s81 - s82
Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson's disease L. MorganteA. EpifanioA. Quattrone Pages: s89 - s90
Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors L. ParnettiS. AmiciV. Gallai Pages: s95 - s96
High-frequency electrical stimulation of the subthalamic nucleus in Parkinson's disease: kinetic and kinematic gait analysis M. RizzoneM. FerrarinL. Lopiano Pages: s103 - s104
Controlled-release transdermal apomorphine treatment for motor fluctuations in Parkinson's disease L. PrianoG. AlbaniA. Mauro Pages: s99 - s100
CAG mutation effect on rate of progression in Huntington's disease F. SquitieriM. CannellaM. Simonelli Pages: s107 - s108
Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: long-term follow-up A. TavellaB. BergamascoL. Lopiano Pages: s111 - s112
